Chemical and pharmacological characterization of galanthamine, an acetylcholinesterase inhibitor, and its derivatives. A potential application in Alzheimer's disease?
- 1 October 1992
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 27 (7) , 673-687
- https://doi.org/10.1016/0223-5234(92)90087-h
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A long-acting cholinesterase inhibitor reverses spatial memory deficits in micePharmacology Biochemistry and Behavior, 1988
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Pharmacological alleviation of cholinergic lesion induced memory deficits in ratsLife Sciences, 1985
- Alkaloidal constituents of Leucojum asetivum L. (Amaryllidaceae).CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- Preliminary Report: Intracranial Cholinergic Drug Infusion in Patients with Alzheimer's DiseaseNeurosurgery, 1984
- Effects of 4-Aminopyridine in Elderly Patients with Alzheimer’s DiseaseNew England Journal of Medicine, 1984
- Alkaloids of the amaryllidaceae. A new alkaloid, sanguinine, from Lycoris sanguinea Maxim. var. Kiushiana Makino, and pretazettine from Lycoris radiata Herb.CHEMICAL & PHARMACEUTICAL BULLETIN, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- Studies on the syntheses of heterocyclic compounds. Part CCCXV. Modified total synthesis of (±)-galanthamine through phenol oxidationJournal of the Chemical Society C: Organic, 1969
- Alkaloids of the Amaryllidaceae. VIII. The Structures of Narcissamine, Pseudolycorine and Methylpseudolycorine1Journal of the American Chemical Society, 1956